340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Sovaldi’s Immediate Impact on Medicare Part D Spending Unclear

Pharmacy benefit managers and drugmakers spar over hepatitis C drug 

August 6, 2014— Sovaldi and other expensive new hepatitis C drugs will increase federal Medicare Part D spending by $2.9 billion to $5.8 billion in 2015 and raise Part D premiums by as much as 8.6 percent, pharmacy benefit management companies warn in a new report. … [Read more...]

Over 100 Members of Congress Express Bipartisan Support for 340B

Drug discounts let hospitals and others "do more with less," they say 

July 31, 2014—More than 100 members of Congress have signed letters expressing “bipartisan support” for the 340B drug discount program, which the lawmakers say allows "hundreds of hospitals and other safety net providers across the country to do more with less." … [Read more...]

In Reversal, Amgen Decides to Continue Offering 340B Pricing on Orphan Drugs

Decision announced soon after interpretive rule's release 

July 31, 2014—In response to the Health Resources and Services Administration's new 340B orphan drug exclusion interpretive rule, the biopharmaceutical manufacturer Amgen has decided to continue providing 340B pricing on its orphan-designated products to critical access hospitals, sole community hospitals, rural referral centers, and free-standing cancer hospitals. … [Read more...]

CMS Official Speaks About 340B Duplicate Discounts in Managed Care

Responsibility for prevention rests with states and Medicaid MCOs, Fine says 

July 30, 2014—It is incumbent on the states and their Medicaid managed care contractors to ensure that drugmakers are protected against paying both a 340B discount and a Medicaid rebate on drugs provided to Medicaid managed care enrollees, a Centers for Medicare and Medicaid Services senior pharmacy official said earlier this month during a meeting of 340B stakeholders. … [Read more...]

Senate Subcommittee Would Provide Up to $17 Million for 340B Program

Urges HRSA to move forward on pricing transparency 

July 29, 2014—Senate appropriators have released a draft federal health spending bill for fiscal year 2015 that would provide $10.2 million in appropriated funds for 340B program administration. … [Read more...]

340B Orphan Drug Interpretative Rule Isn’t Binding, HHS Says

Statute imposes obligations, not the rule, government says in court papers 

July 29, 2014—The Department of Health and Human Services filed papers in federal court last week to clarify that requirements under the Health Resources and Services Administration's new 340B orphan drug exclusion interpretative rule come from the 340B statute, not from rule itself. … [Read more...]

340B Drug Discounts Save Providers About $1.6 Billion Annually, RAND Says

Report looks at program's history, purpose, and policy considerations 

July 23, 2014—Safety-net health care providers saved an estimated $1.6 billion in 2011 by participating in the 340B program, a new analysis by the RAND Corp. shows. … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health